Asbestos Laboratory Services (UK) Ltd


ASBESTOS LABORATORY SERVICES (UK) LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2025



































Company Registration Number: 11578497

ASBESTOS LABORATORY SERVICES (UK) LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


CONTENTS									PAGES



Company information									1

Balance sheet									2 to 3

Notes to the financial statements									4 to 8

ASBESTOS LABORATORY SERVICES (UK) LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025


DIRECTORS

W D Godfrey
P L Sandmann
resigned 1 August 2024


SECRETARY

P Sandmann
resigned 1 August 2024

The company no longer has an appointed secretary


REGISTERED OFFICE

Sycamore Court
North Leigh Business Park
North Leigh
Oxon
OX29 6SW


COMPANY REGISTRATION NUMBER

11578497 England and Wales

ASBESTOS LABORATORY SERVICES (UK) LTD

BALANCE SHEET
AS AT 31 MARCH 2025


	Notes	2025		2024
		£		£

FIXED ASSETS
Tangible assets	6		1,216		1,379

CURRENT ASSETS
Stock		2,463		1,855
Debtors	7	23,258		32,848
Cash at bank and in hand		9,173		3,822


		34,894		38,525

CREDITORS: Amounts falling due within one year	8	16,788		28,823
CREDITORS: Amounts falling due within one year


NET CURRENT ASSETS			18,106		9,702


TOTAL ASSETS LESS CURRENT LIABILITIES			19,322		11,081

Provisions for liabilities and charges			231		-


NET ASSETS			19,091		11,081


CAPITAL AND RESERVES
Called up share capital			2		2
Distributable profit and loss account			19,089		11,079


SHAREHOLDER'S FUNDS			19,091		11,081

ASBESTOS LABORATORY SERVICES (UK) LTD

BALANCE SHEET
AS AT 31 MARCH 2025


These accounts have been prepared and delivered in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006 and in accordance with the provisions of FRS 102 Section 1A - small entities.

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

Members have not required the company to obtain an audit in accordance with section 476 of the Act.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

As permitted by S444 (5A) of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company’s Profit and Loss Account or Directors Report.


Signed on behalf of the board




W D Godfrey
Director

Date approved by the board: 11 December 2025

ASBESTOS LABORATORY SERVICES (UK) LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1	GENERAL INFORMATION

	Asbestos Laboratory Services (UK) Ltd is a private company limited by shares and incorporated in England and Wales. Its registered office is:

	Sycamore Court
	North Leigh Business Park
	North Leigh
	Oxon
	OX29 6SW

	The financial statements are presented in Sterling, which is the functional currency of the company.

2	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Basis of preparation of financial statements

	These financial statements have been prepared in accordance with applicable United Kingdom accounting standards, including Financial Reporting Standard 102 Section 1A smaller entities 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' ('FRS 102') and the Companies Act 2006.

	Revenue recognition

	Turnover is measured at the fair value of consideration received or receivable. It is recognised in respect of services provided for the collection and analysis of asbestos samples as soon as there is a right to consideration and is determined by reference to the value of the work performed. Turnover is stated net of trade discounts and value added tax.

	The company recognises revenue when the amount of revenue can be measured reliably and when it is probable that future economic benefits will flow to the entity.


	Tangible fixed assets

	Fixed assets are carried at cost less accumulated depreciation and accumulated impairment losses.

	Depreciation has been provided at the following rates so as to write off the cost or valuation of assets less residual value of the assets over their estimated useful lives.

	Plant and machinery					Reducing balance basis at 25% per annum
	Furniture and fittings					Reducing balance basis at 20% per annum
	Computer equipment					Straight line basis at 33% per annum

	On disposal, the difference between the net disposal proceeds and the carrying amount of the item sold is recognised in the profit and loss account, and included within administrative expenses.

ASBESTOS LABORATORY SERVICES (UK) LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


2	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued…)

	Financial Instruments

	A financial asset or financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

	The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

	Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through the profit and loss account.

	Basic financial assets and financial liabilities are initially recognised at transaction price and measured at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction. They are subsequently carried at their amortised cost using the effective interest rate method, less any provision for impairment. If the effect of the time value of money is immaterial, they are measured at cost less impairment.

	Basic financial assets and liabilities which are measured at cost or amortised cost are reviewed for objective impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the profit and loss account immediately.

Any reversals of impairment are recognised in the profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset or liability which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.


	Financing transactions are measured at the present value of the future receipts discounted at a market rate of interest. They are subsequently measured at amortised costs using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

	Impairment of non-financial assets

	At each reporting date non-financial assets not carried at fair value, like goodwill and plant, property and equipment, are reviewed to determine whether there is an indication that an asset may be impaired. If there is an indication of possible impairment, the recoverable amount of any asset or group of related assets (which is the higher of value in use and the fair value less cost to sell) is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is reduced to its recoverable amount and an impairment loss is recognised immediately in the profit and loss account.

	Stocks are assessed for impairment at each reporting date. The carrying amount of each item of stock, or group of similar items, is compared with its selling price less cost to complete and sell. If an item of stock, or group of similar items, is impaired its carrying amount is reduced to selling price less costs to complete and sell, and an impairment loss is recognised immediately in the profit and loss account.

	If an impairment loss is subsequently reversed, the carrying amount of the asset, or group of related assets, is increased to the revised estimate of its recoverable amount, but not to exceed the amount that would have been determined had no impairment loss been recognised for the asset, or group of related assets, in prior periods. A reversal of an impairment loss is recognised immediately in the profit and loss account.

ASBESTOS LABORATORY SERVICES (UK) LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued…)

	Stock

	Stock has been valued at the lower of cost and estimated selling price less cost to complete and sell, after making due allowance for obsolete and slow-moving items. Cost comprises materials purchased.

	Debtors

	Short term debtors are measured at transaction price, less any impairment.

	Creditors

	Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and subsequently at amortised cost.

	Taxation

	Taxation expense represents the aggregate amount of current tax and deferred tax recognised in the reporting period.

	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods based on current tax rates and laws. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period.

	Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other taxable profits.

	Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

	Current and deferred tax assets and liabilities are not discounted.

	Pensions

	The company operates a defined contribution pension scheme. The amount charged to the profit and loss account in respect of pension costs and other post-retirement benefits is the amount payable in the year. Differences between contributions payable and contributions actually paid in the year are shown as either accruals or prepayments in the balance sheet.

ASBESTOS LABORATORY SERVICES (UK) LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


3	CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS

	No significant accounting estimates and judgements have had to be made by the directors in preparing these financial statements.

4	EMPLOYEES

	The average number of persons employed by the company (including directors) during the year was:

				2025	2024
	Average number of employees			5	6


6	TANGIBLE ASSETS
		Plant and machinery	Furniture and fittings	Computer equipment	Total
		£	£	£	£
	Cost
	At 1 April 2024	3,457	464	5,129	9,050

	Additions	-	-	589	589


	At 31 March 2025	3,457	464	5,718	9,639


	Accumulated depreciation and impairments
	At 1 April 2024	2,718	206	4,747	7,671

	Charge for year	185	52	515	752


	At 31 March 2025	2,903	258	5,262	8,423


	Net book value
	At 1 April 2024	739	258	382	1,379


	At 31 March 2025	554	206	456	1,216


7	DEBTORS
				2025	2024
				£	£
	Trade debtors			21,643	26,376
	Prepayments and accrued income			1,365	5,301
	Other debtors			250	1,171


				23,258	32,848

ASBESTOS LABORATORY SERVICES (UK) LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


8	CREDITORS: Amounts falling due within one year
			2025	2024
			£	£
	Bank loans and overdrafts		1,583	2,583
	Trade creditors		2,118	6,906
	Taxation and social security		10,595	8,810
	Accruals and deferred income		2,492	4,950
	Other creditors		-	5,574


			16,788	28,823


9	RELATED PARTY TRANSACTIONS

	The company has claimed exemptions from reporting disclosure of related party transactions with the following wholly owned group members:

	Amiantus Holdings Ltd	Parent company